TV presenter Johnny Ball, 87, has revealed that he was diagnosed with prostate cancer in August 2022 and underwent three months of daily radiotherapy. Thankfully, his treatment was successful, and he has now confirmed that he is “through it” and “fine.” Ball, father of BBC Radio 2 DJ Zoe Ball is best known for presenting children’s television programmes such as Play School and Think Of A Number. His willingness to speak publicly about his pr...

We’re delighted to announce a collaboration between GFCT Treatment Support, Vista Health (part of the InHealth Group), and Aqua Medical to provide NHS hospitals with a range of cost-effective and flexible options for MRI scans, ongoing biopsies or a mixture of both as outlined in the attached summary document. What’s on Offer  Mobile MRI Scanning Unit  Available at current NHS tariffs: £149 (non-contrast) and £273 (contrast). Consecutive b...

Tennis legend Björn Borg has revealed that he is battling an aggressive form of prostate cancer. Despite his history of rigorous fitness and regular health checks, this disease still struck. Borg underwent surgery in 2024 and is now in remission, but he will continue tests every six months. What we know about Björn Borg’s diagnosis  Borg’s cancer was described as “extremely aggressive.”  He had surgery in 2024.  He is curr...

Graham Fulford, founder of GFCT and GFCT Treatment Support, was diagnosed with prostate cancer early this year. An update from Graham: I have received my latest PSA result within 24 hours of giving the sample - the NHS at its best! At 2.1, it's slightly down compared to May's result of 2.4. Interestingly, the supporting notes say that the reporting level for me is 6.6 based on age related guidelines, reissued on 25th April. As my PSA level has been historically l...

The Transform Trial is a multi-million pound project designed to change how aggressive prostate cancer is detected at the earliest stage – a goal we all share. About the Trial Recruitment will be GP-led, starting with 10,000–12,000 men over 2–3 years, with the aim of expanding to 200,000–300,000 men nationwide. Participants will be split into two groups:  Testing group: A mix of approaches, including PSA alone, PSA with MR...

How do you look after the health of your workforce?At GFCT, we run workplace health testing events that make it easy for employees to take control of their health.For male-dominated industries (police, construction, transport, manufacturing), we provide PSA testing – a simple blood test that can help detect prostate cancer early, when it’s most treatable.For mixed teams, we also offer general health tests including cholesterol and diabetes checks – helping staff catch potential...

From our founder, Graham: "Monday 8th September was an interesting day in the journey of the charity. Firstly, a very positive article in the Daily Telegraph about the efforts the charity is making to increase the awareness of prostate cancer. Followed by Sue, my beloved and long suffering wife, and I not only completing the last leg of the 630 mile South West Coast Path walk but also celebrating our 52nd wedding anniversary. It's not often that 3 such important events ha...

What if a simple blood test today could save your life tomorrow? Find out how… Through conducting over 16,000 health tests, our results show that around 39% of adults score outside normal ranges on their health tests. Our Testing Events With help from partner organisations, we organise health testing events all over the UK for the public to attend. Simply register online, book your slot and turn up for a quick blood test. What can you get a test for? Your blo...

A recent report has revealed that thousands of men with prostate cancer in England are being denied access to abiraterone, a low-cost drug that could save hundreds of lives each year. What is Abiraterone?  Blocks the production of testosterone, which fuels prostate cancer growth.  Already available on the NHS for men with advanced, incurable cancer.  A 2022 clinical trial proved it is also effective for men with high-risk cancer that has not...

Today’s Telegraph article featured GFCT and our mission to make PSA testing more accessible for men across the UK. If you’re new to hearing about our work, please have a read of this summary to learn about what we do and how it might save your life. Testing in the Community At our recent event in Warwick’s Nelson Club, nearly 200 men attended for a simple PSA blood test. These events (hosted in community spaces like clubs, churches, and sports...